Sumitomo Chemical India logo

Sumitomo Chemical India MD, chairman, board of directors and AGM

NSE: SUMICHEMBSE: 542920Fertilizers & AgrochemicalsSmall Cap

Last close ₹360.60down ₹9.90 (2.67%)BSE ₹360.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹370.50.

52-week range of traded prices to 23 Oct 2026
₹358.20Low, 23 Oct 2026₹572.05High, 17 Aug 2026
Market cap
₹17,999 Cr328th largest listed
P/E
31.1
P/B
5.3
Dividend yield
0.36%
ROE
18.4%
ROCE
18.2%
Debt to equity
0.00
Volume, NSE
3,47,16161.4% delivered

Sumitomo Chemical India board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonCHETAN SHANTILAL SHAH
  • Managing directorSURESH RAMACHANDRAN
  • Company Secretary and Compliance OfficerDEEPIKA TRIVEDI

7 directors3 independent1 executive3 non-executive

  • CHETAN SHANTILAL SHAH · ChairpersonNon-executive · joined Sep 2019 · reappointed Sep 2026 · 82 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • SURESH RAMACHANDRAN · Managing directorExecutive · joined Jun 2023 · reappointed Sep 2026 · 40 months as independent · 1 listed board
  • TADASHI KATAYAMANon-executive · joined Aug 2019 · reappointed Jul 2024 · 82 months as independent · 1 listed board · 1 committee seat
  • PREETI G. MEHTAIndependent · joined Aug 2019 · reappointed Aug 2024 · 82 months as independent · 2 listed boards · 1 as independent · 1 committee seat
  • MASANORI UZAWANon-executive · joined Jul 2020 · reappointed Jul 2023 · 72 months as independent · 1 listed board
  • SIVARAMAN NARAYANASWAMIIndependent · joined Sep 2024 · reappointed Aug 2026 · 25 months as independent · 3 listed boards · 2 as independent · 4 committee seats, 2 as chair
  • ANAND MOHAN TIWARIIndependent · joined Aug 2026 · 2 months as independent · 3 listed boards · 3 as independent · 6 committee seats, 2 as chair

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

3 directors who left
  • MUKUL GOVINDJI ASHER, left 31 Aug 2026: Tenure Completion
  • SUSHIL CHAMPAKLAL MARFATIA, left 31 Aug 2026: Tenure Completion
  • NINAD DWARKANATH GUPTE, left 31 Aug 2026: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 27 Jul 20269 of 9 present3 independent · 61 days in between
    • 26 May 20269 of 9 present3 independent

  • Audit Committee

    Chair SIVARAMAN NARAYANASWAMI

    TADASHI KATAYAMA, PREETI G. MEHTA

    • 27 Jul 20264 of 4 present3 independent · 61 days in between
    • 26 May 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair PREETI G. MEHTA

    TADASHI KATAYAMA, SIVARAMAN NARAYANASWAMI

    No meeting listed in the filing.

  • Stakeholders Relationship Committee

    Chair CHETAN SHANTILAL SHAH

    ANAND MOHAN TIWARI, SURESH RAMACHANDRAN

    No meeting listed in the filing.

  • Risk Management Committee

    Chair CHETAN SHANTILAL SHAH

    SURESH RAMACHANDRAN, MASANORI UZAWA, PREETI G. MEHTA, KUNAL MITTAL, V. GOPALAKRISHNAN, ANIL NAWAL

    • 16 Sep 20264 of 4 present2 independent · 50 days in between

  • Corporate Social Responsibility Committee

    Chair CHETAN SHANTILAL SHAH

    PREETI G. MEHTA, ANAND MOHAN TIWARI, SURESH RAMACHANDRAN

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • BSR & CO. LLPPeer-review certificate valid to Jul 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Sumitomo Chemical India AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sumitomo Chemical India dividend history

Annual general meeting, 27 Jul 2026

1,12,060 shareholders on the register on 20 Jul 2026; present: 1 promoter and 64 others; votes counted by KAMALAX G SARAF / M K SARAF & ASSOCIATES LLP.The company's voting result (opens in a new tab)

  1. Adoption of the Audited Financial Statements (including the Consolidated Financial Statements) of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  2. Declaration of Dividend of Rs1.30 per equity share.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  3. Appointment of Dr. Suresh Ramachandran, who retired by rotation and, being eligible, offered himself for re-appointment.
    Ordinary
    98.79% for1.21% against

    Against: promoters 0.00% · institutions 9.74% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  4. Reappointment of Mr. N. Sivaraman as an Independent Director with effect from 1st September, 2026 for the second term for three years.
    Special
    98.64% for1.36% against

    Against: promoters 0.00% · institutions 10.96% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  5. Appointment of Mr. Anand Mohan Tiwari as an Independent Director with effect from 31st August, 2026 for a term of two years.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  6. Appointment of Mr. Chetan Shah, presently Managing Director whose tenure as MD concludes on 31st August, 2026, as a Non-Executive Non-Independent Director with effect from 1 September 2026.
    Ordinary
    99.12% for0.88% against

    Against: promoters 0.00% · institutions 7.10% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  7. Promotion of Dr. Suresh Ramachandran, presently Deputy Managing Director, to the position of Managing Director with effect from 1st September, 2026
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.10% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  8. Payment of advisory fees, commission and sitting fees to Mr. Chetan Shah for one year period from 1st September, 2026
    Special
    96.16% for3.84% against

    Against: promoters 0.00% · institutions 31.04% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

  9. Approval for material related party transactions entered into and proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2026-27
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 10.89% · promoters 0.00% · institutions 85.24% · other public 2.07%

  10. Ratification of the remuneration of M/s. GMVP & Associates LLP, the Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.07%

    Turnout: all 85.89% · promoters 100.00% · institutions 85.24% · other public 2.07%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 4 Aug 2025, 6 resolutions

1,21,978 shareholders on the register on 28 Jul 2025; present: 1 promoter and 49 others; votes counted by KAMALAX G SARAF / M K SARAF & ASSOCIATES LLP.The company's voting result (opens in a new tab)

  1. Adoption of the audited financial statements of the Company for the financial year ended 31 March 2025 together with the Reports of the Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.14% · promoters 100.00% · institutions 87.08% · other public 5.19%

  2. Declaration of dividend on equity shares of Rs. 1.20 per equity share.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.16% · promoters 100.00% · institutions 87.20% · other public 5.19%

  3. Appointment of a director in place of Mr. Ninad D. Gupte (DIN: 00027523), who retires by rotation and, being eligible, offers himself for reappointment.
    Ordinary
    98.20% for1.80% against

    Against: promoters 0.00% · institutions 14.82% · other public 0.00%

    Turnout: all 86.14% · promoters 100.00% · institutions 87.08% · other public 5.19%

  4. Appointment of secretarial auditors of the Company.
    Ordinary
    99.06% for0.94% against

    Against: promoters 0.00% · institutions 7.74% · other public 0.00%

    Turnout: all 86.14% · promoters 100.00% · institutions 87.08% · other public 5.19%

  5. Approval of transactions entered into/proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2025-26.
    OrdinaryPromoters have an interest in it
    92.73% for7.27% against

    Against: promoters 0.00% · institutions 7.74% · other public 0.00%

    Turnout: all 11.14% · promoters 0.00% · institutions 87.08% · other public 5.19%

  6. Ratification of the remuneration of the Cost Auditors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.14% · promoters 100.00% · institutions 87.08% · other public 5.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2024, 10 resolutions

Present: 1 promoter and 58 others.The company's voting result (opens in a new tab)

  1. Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2024 together with the Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  2. Declaration of Final Dividend at the rate of Rs. 0.90 per equity share
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  3. Appointment of Mr. Tadashi Katayama (DIN: 07628973), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    97.27% for2.73% against

    Against: promoters 0.00% · institutions 26.48% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  4. Appointment of Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  5. To reappoint Mr. Mukul G. Asher (DIN: 00047673) as an Independent Director
    Special
    96.67% for3.33% against

    Against: promoters 0.00% · institutions 32.27% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  6. To reappoint Mrs. Preeti Mehta (DIN: 00727923) as an Independent Director
    Special
    94.75% for5.25% against

    Against: promoters 0.00% · institutions 50.97% · other public 0.01%

    Turnout: all 85.34% · promoters 100.00% · institutions 83.29% · other public 10.69%

  7. To appoint Mr. N. Sivaraman (DIN: 00001747) as an Independent Director
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  8. To promote Dr Suresh Ramachandran (DIN: 03110244) to the position of Deputy Managing Director
    Special
    96.82% for3.18% against

    Against: promoters 0.00% · institutions 30.86% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

  9. Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2024-25
    OrdinaryPromoters have an interest in it
    98.44% for1.56% against

    Against: promoters 0.00% · institutions 1.84% · other public 0.01%

    Turnout: all 10.35% · promoters 0.00% · institutions 83.36% · other public 10.69%

  10. Ratification of the remuneration of the Cost Auditors for the year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 85.35% · promoters 100.00% · institutions 83.36% · other public 10.69%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Jul 2023, 8 resolutions

Present: 8 promoters and 43 others.The company's voting result (opens in a new tab)

  1. Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2023 together with the Reports of the Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

  2. Declaration of Dividend at the rate of Rs. 1.20 per equity share.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

  3. Appointment of Mr. Masanori Uzawa (DIN: 08782828), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation.
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 1.81% · other public 0.05%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

  4. To appoint Dr. Suresh Ramachandran as Whole-time Director.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.01%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.95%

  5. To reappoint Mr. Chetan Shah as Managing Director.
    Special
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 1.08% · other public 0.06%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

  6. To reappoint Mr. Sushil Marfatia as Executive Director.
    Special
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 1.07% · other public 0.06%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

  7. Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2023-24.
    OrdinaryPromoters have an interest in it
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 7.16% · promoters 0.00% · institutions 77.88% · other public 4.95%

  8. Ratification of the remuneration of the Cost Auditors for the year 2023-24.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.05%

    Turnout: all 82.16% · promoters 100.00% · institutions 77.88% · other public 4.96%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Jul 2022, 8 resolutions

Present: 7 promoters and 55 others.The company's voting result (opens in a new tab)

  1. Adoption of the Audited Financial Statements of the Company for the financial year ended 31st March, 2022 and the Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  2. Declaration of Dividend of ₹ 1.00 per share
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  3. Appointment of Mr. Hiroyoshi Mukai (DIN: 07835814), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.28%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  4. Appointment of Mr. Ninad D. Gupte (DIN: 00027523), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.29%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  5. Reappointment of Mr. Chetan Shah as Managing Director for a period of one year w.e.f. 1st September, 2022
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.29%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  6. Reappointment of Mr. Sushil Marfatia as Executive Director for a period of one year w.e.f. 1st September, 2022
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.29%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

  7. Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2022-23
    OrdinaryPromoters have an interest in it
    92.50% for7.50% against

    Against: promoters 0.00% · institutions 8.08% · other public 0.32%

    Turnout: all 5.26% · promoters 0.00% · institutions 56.59% · other public 2.39%

  8. Ratification of the remuneration of the Cost Auditors for the year 2022-23
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.13% · other public 0.29%

    Turnout: all 80.26% · promoters 100.00% · institutions 56.59% · other public 2.39%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2021, 8 resolutions

Present: 2 promoters and 83 others.The company's voting result (opens in a new tab)

  1. Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2021 together with the Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  2. Declaration of Dividend at the rate of ?0.80 per equity share
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  3. Appointment of Mr. Tadashi Katayama, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    99.96% for0.04% against

    Against: promoters 0.00% · institutions 1.05% · other public 0.00%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  4. Appointment of Mr. Sushil Marfatia, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  5. Revision of the terms and conditions of compensation of Mr. Chetan Shah, Managing Director
    Special
    99.27% for0.73% against

    Against: promoters 0.00% · institutions 17.64% · other public 0.02%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  6. Revision of the terms and conditions of compensation of Mr. Sushil Marfatia, Executive Director
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

  7. Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2021-22
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 4.07% · promoters 0.00% · institutions 41.75% · other public 4.67%

  8. Ratification of the remuneration of the Cost Auditors for the year 2021-22
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 79.07% · promoters 100.00% · institutions 41.75% · other public 4.67%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 10 Sep 2020, 5 resolutions

Present: 2 promoters and 90 others.The company's voting result (opens in a new tab)

  1. Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2020 together with the Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.76%

    Turnout: all 80.29% · promoters 100.00% · institutions 33.39% · other public 0.10%

  2. Declaration of final Dividend at the rate of rRs.0.55 per equity share
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.76%

    Turnout: all 80.29% · promoters 100.00% · institutions 33.39% · other public 0.10%

  3. Appointment of Mr. Ninad D. Gupte, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Ordinary
    99.94% for0.06% against

    Against: promoters 0.00% · institutions 2.44% · other public 2.05%

    Turnout: all 80.29% · promoters 100.00% · institutions 33.39% · other public 0.10%

  4. Appointment of Mr. Masanori Uzawa as a Director liable to retire by rotation
    Ordinary
    99.94% for0.06% against

    Against: promoters 0.00% · institutions 2.38% · other public 2.05%

    Turnout: all 80.29% · promoters 100.00% · institutions 33.39% · other public 0.10%

  5. Ratification of the remuneration of the Cost Auditors for the year 2020-21
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.76%

    Turnout: all 80.29% · promoters 100.00% · institutions 33.39% · other public 0.10%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 27 Jul 2026, 12 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the Audited Financial Statements (including the Consolidated Financial Statements) of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon.MoreLess
    12 for0 against
  • Declaration of Dividend of Rs1.30 per equity share.
    12 for0 against
  • Appointment of Dr. Suresh Ramachandran, who retired by rotation and, being eligible, offered himself for re-appointment.
    11 for0 against
  • Reappointment of Mr. N. Sivaraman as an Independent Director with effect from 1st September, 2026 for the second term for three years.
    Against HSBC Mutual Fund
    • HSBC Mutual FundWe are voting against the longest serving non-executive director as the level of board independence falls below our expectation
    11 for1 against
  • Appointment of Mr. Anand Mohan Tiwari as an Independent Director with effect from 31st August, 2026 for a term of two years.
    12 for0 against
  • Appointment of Mr. Chetan Shah, presently Managing Director whose tenure as MD concludes on 31st August, 2026, as a Non-Executive Non-Independent Director with effect from 1 September 2026.
    12 for0 against
  • Promotion of Dr. Suresh Ramachandran, presently Deputy Managing Director, to the position of Managing Director with effect from 1st September, 2026
    11 for0 against
  • Payment of advisory fees, commission and sitting fees to Mr. Chetan Shah for one year period from 1st September, 2026
    Against HSBC Mutual Fund
    • HSBC Mutual FundThere is insufficient justification for the proposed remuneration, which is almost at par to that paid to other executive directors of the company.
    11 for1 against
  • Approval for material related party transactions entered into and proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2026-27
    12 for0 against
  • Ratification of the remuneration of M/s. GMVP & Associates LLP, the Cost Auditors
    12 for0 against
2 proposals not matched to one resolution
  • Reappoint Dr. Suresh Ramachandran (DIN: 03110244) as Director, liable to retire by rotation
    1 for0 against
  • Redesignate Dr. Suresh Ramachandran (DIN: 03110244) as Managing Director from 1 September 2026 till the completion of his tenure on 31 May 2028 and fix his remuneration
    1 for0 against

Mutual fund votes, meeting of 4 Aug 2025, 25 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the audited financial statements of the Company for the financial year ended 31 March 2025 together with the Reports of the Board of Directors and Auditors thereon.
    25 for0 against
  • Declaration of dividend on equity shares of Rs. 1.20 per equity share.
    25 for0 against
  • Appointment of a director in place of Mr. Ninad D. Gupte (DIN: 00027523), who retires by rotation and, being eligible, offers himself for reappointment.
    25 for0 against
  • Appointment of secretarial auditors of the Company.
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundTransparency concern: Remuneration of outgoing auditor not disclosed; thus, material change, if any, with proposed audit fee cannot be ascertained.
    • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. Transparency concern: Remuneration of outgoing auditor not disclosed; thus, material change, if any, with proposed audit fee cannot be ascertained.
    20 for5 against
  • Approval of transactions entered into/proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2025-26.
    Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance Concern: Basis for Arm’s Length pricing not disclosed.
    • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed.
    • Kotak Mahindra Mutual FundThe company seeks approval for related party transactions with Sumitomo Chemical Company Limited, Japan for the sale, purchase and supply of goods including raw materials, finished products, intermediates, capital goods and other items, for providing and availing services and other transactions. Sumitomo Chemical Company Ltd. holds a ~75.0% stake in the company. The RPTs are operational in nature relating to sales/purchase of goods and reimbursement of expenses. The company has not clarified with respect to the arm s length basis of the transactions. Hence, we do not support the resolution. So, we are voting against.
    19 for6 against
  • Ratification of the remuneration of the Cost Auditors.
    5 for0 against
2 proposals not matched to one resolution
  • 6. To ratify the remuneration of Rs. 550,000 plus applicable taxes and duties and reimbursement of actual out-of-pocket expenses fixed by the Board of Directors of the Company payable to Messrs GMVP and Associates LLP, Cost Accountants (Registration Number: 000910), in respect of the cost audit for the financial year 2025-26.MoreLess
    1 for0 against
  • To ratify the remuneration of Rs. 550,000 plus applicable taxes and duties and reimbursement of actual out-of-pocket expenses fixed by the Board of Directors of the Company payable to Messrs GMVP and Associates LLP, Cost Accountants (Registration Number: 000910), in respect of the cost audit for the financial year 2025-26.MoreLess
    19 for0 against
5 earlier meetings

Mutual fund votes, meeting of 30 Jul 2024, 20 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2024 together with the Reports of the Board of Directors and Auditors thereon
    20 for0 against
  • Declaration of Final Dividend at the rate of Rs. 0.90 per equity share
    20 for0 against
  • Appointment of Mr. Tadashi Katayama (DIN: 07628973), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    Against HSBC Mutual Fund
    • HSBC Mutual FundA Vote AGAINST this resolution is warranted. The board independence norms are not met (after reclassification) and Tadashi Katayama is a non-independent director nominee.
    19 for1 against
  • Appointment of Auditors of the Company
    4 for0 against
  • To reappoint Mr. Mukul G. Asher (DIN: 00047673) as an Independent Director
    Against Groww Mutual Fund, HSBC Mutual Fund, JM Financial Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual Fund
    • Groww Mutual Fund, JM Financial Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundCompliant with law. No concern on the merit of proposed appointee. Governance concern: Prolonged association with the Group
    • HSBC Mutual FundA vote AGAINST re-election of Mukul Asher is warranted given his association with the merged entity, exceedsmore than ten years, thus affecting his independence.
    • Zerodha Mutual FundGovernance concern: Prolonged association with the Group
    14 for6 against
  • To reappoint Mrs. Preeti Mehta (DIN: 00727923) as an Independent Director
    Against 360 One Mutual Fund, Bandhan Mutual Fund, DSP Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund, JM Financial Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Zerodha Mutual Fund
    • 360 One Mutual FundMs. Preeti Mehta, 64, is a Partner at Kanga & Co. – a law firm. She has been an Independent Director on the board of the company since 31 August 2019. She has attended all five board meetings in FY24 (100%). We do not support her reappointment because Kanga & Co., had acted as an advisor to Excel Crop Care Limited (now merged with the company) in the merger transaction with SCIL in 2019. Further, SCIL has entered into related party transactions with Kanga & Co. for “purchase of services” since FY20. We believe that any business transaction – irrespective of the materiality of the transaction – may impair the objectivity and independence of the director. We raise concerns on the potential conflict of interest. Ms. Mehta had been on the board of Excel Crop Care since 7 October 2016 since its merger with SCIL. Aggregated with her current and proposed tenure at SCIL, her association with the group will cross ten years. We do not support rotation of tenured Independent Directors within the group as we believe that this is not in line with the spirit of the regulations. We note that she serves on the boards of four listed companies (including SCIL). Given their full-time responsibilities, regulations allow whole-time directors of listed companies to be independent directors in a maximum of three listed companies. Further, we believe that as a Partner at Kanga & Co., her responsibilities are equivalent to a whole-time directorship. Therefore, her high number of directorships on listed companies is not in keeping with the spirit of the regulation
    • Bandhan Mutual Fund, Groww Mutual Fund, JM Financial Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundCompliant with law. No concern on the merit of proposed appointee. Governance concern: Proposed term will lead to prolonged association with the Group
    • DSP Mutual FundMs. Preeti Mehta, 64, is a Partner at Kanga & Co. – a law firm. She has been an Independent Director on the board of the company since 31 August 2019. She has attended all five board meetings in FY24 (100%). We do not support her reappointment because Kanga & Co., had acted as an advisor to Excel Crop Care Limited (now merged with the company) in the merger transaction with SCIL in 2019. Further, SCIL has entered into related party transactions with Kanga & Co. for “purchase of services” since FY20. We believe that any business transaction – irrespective of the materiality of the transaction – may impair the objectivity and independence of the director. We raise concerns on the potential conflict of interest.Ms. Mehta had been on the board of Excel Crop Care since 7 October 2016 since its merger with SCIL. Aggregated with her current and proposed tenure at SCIL, her association with the group will cross ten years. We do not support rotation of tenured Independent Directors within the group as we believe that this is not in line with the spirit of the regulations.We note that she serves on the boards of four listed companies (including SCIL). Given their full-time responsibilities, regulations allow whole-time directors of listed companies to be independent directors in a maximum of three listed companies. Further, we believe that as a Partner at Kanga & Co., her responsibilities are equivalent to a whole-time directorship. Therefore, her high number of directorships on listed companies is not in keeping with the spirit of the regulation.
    • HDFC Mutual FundHer appointment could create a conflict of interest as she was directly involved in company's M&A activities.
    • HSBC Mutual FundA vote AGAINST this resolution is warranted because Preeti Mehta's current appointment will exceed hisassociation with the merged entity for more than ten years, thus affecting her independence.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Nippon India Mutual FundProlonged association
    • Zerodha Mutual FundGovernance concern: Prolonged association with the Group
    8 for12 against
  • To appoint Mr. N. Sivaraman (DIN: 00001747) as an Independent Director
    20 for0 against
  • To promote Dr Suresh Ramachandran (DIN: 03110244) to the position of Deputy Managing Director
    Against HSBC Mutual Fund
    • HSBC Mutual FundA vote AGAINST this resolution is warranted as the board independence norms are not met (afterreclassification) and Suresh Ramachandran is a non-independent director nominee.
    19 for1 against
  • Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2024-25
    Against Groww Mutual Fund, JM Financial Mutual Fund, Motilal Oswal Mutual Fund, Zerodha Mutual Fund
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed Transparency concern: No clarity with regards to obtaining prior approval from shareholders for proposed related party transactions
    • JM Financial Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed Transparency concern: No clarity with regards to obtaining prior approval from shareholders for proposed Related Party Transactions
    • Zerodha Mutual FundBasis for Arm’s Length not disclosed, no clarity on obtaining Prior Shareholders’ approval.
    16 for4 against
  • Ratification of the remuneration of the Cost Auditors for the year 2024-25
    19 for0 against
3 proposals not matched to one resolution
  • Appointment of Messrs BSR and Co. LLP, Chartered Accountants (ICAI Firm Registration No. 101248W/W-100022), as Auditors of the Company to hold office from the conclusion of this annual general meeting, until the conclusion of the twenty ninth annual general meeting of the Company on a remuneration of Rs. 3,500,000 for the financial year 2024- 25.MoreLess
    15 for0 against
  • Approve BSR & Co. LLP, Chartered Accountants as Auditors and Authorize Board to Fix Their Remuneration
    1 for0 against
  • To ratify the remuneration of Rs. 550,000 plus applicable taxes and duties and reimbursement of actual out- of- pocket expenses fixed by the Board of Directors of the Company payable to Messrs GMVP and Associates LLP, Cost Accountants (Registration Number: 000910), in respect of the cost audit for the financial year 2024- 25.MoreLess
    1 for0 against

Mutual fund votes, meeting of 28 Jul 2023, 16 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2023 together with the Reports of the Board of Directors and Auditors thereon.
    15 for0 against
  • Declaration of Dividend at the rate of Rs. 1.20 per equity share.
    15 for0 against
  • Appointment of Mr. Masanori Uzawa (DIN: 08782828), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation.
    15 for0 against
  • To appoint Dr. Suresh Ramachandran as Whole-time Director.
    15 for0 against
  • To reappoint Mr. Chetan Shah as Managing Director.
    15 for0 against
  • To reappoint Mr. Sushil Marfatia as Executive Director.
    15 for0 against
  • Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2023-24.
    15 for0 against
  • Ratification of the remuneration of the Cost Auditors for the year 2023-24.
    15 for0 against
8 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 5, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 29 Jul 2022, 13 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the Audited Financial Statements of the Company for the financial year ended 31st March, 2022 and the Reports of the Board of Directors and Auditors thereon
    12 for0 against
  • Declaration of Dividend of ₹ 1.00 per share
    12 for0 against
  • Appointment of Mr. Hiroyoshi Mukai (DIN: 07835814), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    12 for0 against
  • Appointment of Mr. Ninad D. Gupte (DIN: 00027523), who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    12 for0 against
  • Reappointment of Mr. Chetan Shah as Managing Director for a period of one year w.e.f. 1st September, 2022
    13 for0 against
  • Reappointment of Mr. Sushil Marfatia as Executive Director for a period of one year w.e.f. 1st September, 2022
    12 for0 against
  • Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2022-23
    Against JM Financial Mutual Fund
    • JM Financial Mutual FundCompliant with law. Governance concern: Inadequate disclosure
    11 for1 against
  • Ratification of the remuneration of the Cost Auditors for the year 2022-23
    Against JM Financial Mutual Fund
    • JM Financial Mutual FundCompliant with law. Governance Concern: Cost Audit fee significantly lower than the minimum suggested fee by ICAI.
    11 for1 against
7 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 4, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 8, as a fund house numbered it
    1 for0 against

Mutual fund votes, meeting of 30 Jul 2021, 10 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2021 together with the Reports of the Board of Directors and Auditors thereon
    9 for0 against
  • Declaration of Dividend at the rate of ?0.80 per equity share
    9 for0 against
  • Appointment of Mr. Tadashi Katayama, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    10 for0 against
  • Appointment of Mr. Sushil Marfatia, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    10 for0 against
  • Revision of the terms and conditions of compensation of Mr. Chetan Shah, Managing Director
    Against Bank of India Mutual Fund, Invesco Mutual Fund, JM Financial Mutual Fund, Taurus Mutual Fund
    • Bank of India Mutual Fund, Taurus Mutual FundChetan Shah, 66, has extensive experience in the agrochemicals industry of over 43 years. He was appointed as the Managing Director for three years from 1 September 2019. His term expires on 31 August 2022. The company seeks approval to revise his remuneration effective 1 April 2020. He received Rs. 64. 4 mn as remuneration in FY21. His estimated remuneration for FY22 is Rs. 80. 0 mn including aggregate performance bonus upto Rs. 30. 0 mn, the metrics for which have not been disclosed. At maximum payout, his remuneration could range upto Rs. 96. 0 mn annually. His estimated remuneration is high compared to peers and not commensurate with the size and complexity of the business.
    • Invesco Mutual FundChetan Shah, 66, has extensive experience in the agrochemicals industry of over 43 years. He was appointed as the Managing Director for three years from 1 September 2019. His term expires on 31 August 2022. The company seeks approval to revise his remuneration effective 1 April 2020. He received Rs. 64.4 mn as remuneration in FY21. His estimated remuneration for FY22 is Rs. 80.0 mn including aggregate performance bonus upto Rs. 30.0 mn, the metrics for which have not been disclosed. At maximum payout, his remuneration could range upto Rs. 96.0 mn annually. His estimated remuneration is high compared to peers and not commensurate with the size and complexity of the business.
    • JM Financial Mutual FundChetan Shah, 66, has extensive experience in the agrochemicals industry of over 43 years. He was appointed as the Managing Director for three years from 1 September 2019. His term expires on 31 August 2022. The company seeks approval to revise his remuneration effective 1 April 2020.He received Rs. 64.4 mn as remuneration in FY21. His estimated remuneration for FY22 is Rs. 80.0 mn including aggregate performance bonus upto Rs. 30.0 mn, the metrics for which have not been disclosed. At maximum payout, his remuneration could range upto Rs. 96.0 mn annually. His estimated remuneration is high compared to peers and not commensurate with the size and complexity of the business.
    6 for4 against
  • Revision of the terms and conditions of compensation of Mr. Sushil Marfatia, Executive Director
    10 for0 against
  • Approval for transactions entered into / proposed to be entered into with Sumitomo Chemical Company, Limited, a related party, during the Financial Year 2021-22
    10 for0 against
  • Ratification of the remuneration of the Cost Auditors for the year 2021-22
    9 for0 against
3 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Ratify remuneration of Rs. 550,000 plus applicable taxes and reimbursement of out of pocket expenses to GMVP & Associates as cost auditors for FY22
    1 for0 against

Mutual fund votes, meeting of 10 Sep 2020, 5 fund houses

  • Adoption of the audited financial statements of the Company for the financial year ended 31st March, 2020 together with the Reports of the Board of Directors and Auditors thereon
    2 for0 against

    3 abstained

  • Declaration of final Dividend at the rate of rRs.0.55 per equity share
    2 for0 against

    3 abstained

  • Appointment of Mr. Ninad D. Gupte, who retires by rotation and, being eligible, offers himself for re-appointment, as a Director liable to retire by rotation
    2 for0 against

    3 abstained

  • Appointment of Mr. Masanori Uzawa as a Director liable to retire by rotation
    2 for0 against

    3 abstained

  • Ratification of the remuneration of the Cost Auditors for the year 2020-21
    2 for0 against

    3 abstained

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Dec 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.